- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00373698
Re-Engineering Systems for the Primary Care Treatment for PTSD (RESPECT-PTSD)
April 6, 2015 updated by: US Department of Veterans Affairs
Reengineering Systems for the Primary Care Treatment of PTSD
The study is an evaluation of a systemic intervention to enhance the delivery of care according to practice guidelines for posttraumatic stress disorder (PTSD).
The immediate objectives are to (1) implement three component model (3CM) in VA primary care clinics; and (2) evaluate the effects of 3CM on clinician behavior and patient outcomes.
The long-term objectives are to generate information to support implementation research on the RESPECT model for treating PTSD in primary care and ultimately, the implementation of the model in VHA to provide care to veterans with PTSD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
3CM consists of (1) a prepared practice, (2) care management, and (3) enhanced mental health support.
A prepared practice refers to education for primary care clinicians and office staff about practice guidelines and evidence-based care, the skills needed for use of assessment measures, and the use of communication forms and routines.
The education plan consists of predisposing activities, including active teaching and learning, and enabling and reinforcing activities in order to help clinicians use newly acquired skills and to reinforce the continued use of these skills in practice.
Care management is accomplished by telephone, usually by a centrally located care manager during acute phase treatment and follow up to answer patient questions, promote adherence to the clinician's management plan, and help patients overcome barriers to adherence.
Enhanced mental health support is provided by a psychiatrist who supervises care managers by telephone, provides informal consultation to primary care clinicians, and helps to increase the quantity or quality of mental health referral resources.
Study Type
Interventional
Enrollment (Actual)
195
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75216
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
-
Temple, Texas, United States, 76504
- Central Texas Veterans Health Care System, Temple, TX
-
Waco, Texas, United States, 76711
- Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX
-
-
Vermont
-
White River Junction, Vermont, United States, 05009-0001
- White River Junction VA Medical Center, White River Junction, VT
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Military Veterans in Primary Care Clinics who meet diagnostic criteria for PTSD in one of the 5 sites in Texas where this study is being conducted.
- Must have regular access to a telephone and speak English.
Exclusion Criteria:
- Cognitive impairment
- A history of psychosis or mania
- Prominent current suicidal ideation
- Current substance dependence
- Current engagement in mental health treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Three Component Model
Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.
|
Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.
|
No Intervention: Usual Care
Patients randomized to "Usual Care" will receive care as usual by VA clinicians.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PTSD Symptom Severity
Time Frame: 3 and 6 months after initial assessment
|
PTSD Symptom Severity was measured using the Postraumatic Diagnostic Scale (PDS)
|
3 and 6 months after initial assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: 3 and 6 months after initial assessment
|
Measure using the Hopkins Symptom Checklist-20
|
3 and 6 months after initial assessment
|
SF-36 Mental Component
Time Frame: 3 and 6 months after initial assessment
|
3 and 6 months after initial assessment
|
|
SF-36 Physical Component
Time Frame: 3 and 6 months after initial assessment
|
3 and 6 months after initial assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Paula P Schnurr, PhD, White River Junction VA Medical Center, White River Junction, VT
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
April 1, 2010
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
September 6, 2006
First Submitted That Met QC Criteria
September 7, 2006
First Posted (Estimate)
September 8, 2006
Study Record Updates
Last Update Posted (Estimate)
April 24, 2015
Last Update Submitted That Met QC Criteria
April 6, 2015
Last Verified
June 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IAC 06-073
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Three Component Model of Collaborative Care
-
Chulalongkorn UniversityamfAR, The Foundation for AIDS ResearchCompleted
-
McMaster UniversityUnknown
-
Duke-NUS Graduate Medical SchoolMinistry of Health, Singapore; The Tsao FoundationUnknownCognitive Impairment | DementiaSingapore
-
VA Office of Research and DevelopmentNational Institute of Mental Health (NIMH); University of California, Los AngelesCompletedSchizophrenia | Weight Gain | Chronic Illness | Psychotic DisorderUnited States
-
Massachusetts General HospitalActive, not recruitingType 1 Diabetes | Type 2 DiabetesUnited States
-
Trillium Health CentreCentre for Addiction and Mental Health; Medical Psychiatry AllianceCompletedDepression | AnxietyCanada
-
US Department of Veterans AffairsCompletedMyocardial Ischemia | Coronary Disease | Angina PectorisUnited States
-
University of MichiganCompletedDepression | Bipolar DisorderUnited States
-
University of Colorado, DenverUniversity of Alabama at Birmingham; University of North Carolina, Chapel Hill and other collaboratorsNot yet recruitingHuman Immunodeficiency Virus | Mental DisorderKenya
-
University of Texas Southwestern Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedHypertension | Diabetes | Type 2 Diabetes | Chronic Kidney Disease | High BPUnited States